search
Back to results

Effect of Flex-a-New on Osteoarthritis of the Knee

Primary Purpose

Osteoarthritis

Status
Unknown status
Phase
Phase 4
Locations
Israel
Study Type
Interventional
Intervention
flex-a-new (food supplement)
Sponsored by
Rabin Medical Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring knee osteoarthritis

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: knee osteoarthritis grade 1 to 3 - Exclusion Criteria: ischemic heart disease with CHF -

Sites / Locations

  • Rabin Medical CenterRecruiting

Outcomes

Primary Outcome Measures

KOOS

Secondary Outcome Measures

VAS KSS

Full Information

First Posted
February 21, 2006
Last Updated
February 21, 2006
Sponsor
Rabin Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00294801
Brief Title
Effect of Flex-a-New on Osteoarthritis of the Knee
Study Type
Interventional

2. Study Status

Record Verification Date
February 2006
Overall Recruitment Status
Unknown status
Study Start Date
January 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2007 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Rabin Medical Center

4. Oversight

5. Study Description

Brief Summary
comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis
Detailed Description
comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
knee osteoarthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
80 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
flex-a-new (food supplement)
Primary Outcome Measure Information:
Title
KOOS
Secondary Outcome Measure Information:
Title
VAS KSS

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: knee osteoarthritis grade 1 to 3 - Exclusion Criteria: ischemic heart disease with CHF -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
dror robinson
Organizational Affiliation
Rabin Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rabin Medical Center
City
Petah Tikwa
ZIP/Postal Code
49372
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
dror robinson, md
Phone
972-3-9372233
Email
drorr@clalit.org.il
First Name & Middle Initial & Last Name & Degree
dror robinson, md

12. IPD Sharing Statement

Learn more about this trial

Effect of Flex-a-New on Osteoarthritis of the Knee

We'll reach out to this number within 24 hrs